Allison Dane
About Allison Dane
Allison Dane is a Senior Director in R&D at Asklepios BioPharmaceutical, Inc., with a strong background in medical science and gene therapy. She has extensive experience in next generation capsid development and vector production, and has held various research positions in both Australia and the United Kingdom.
Work at Asklepios BioPharmaceutical
Allison Dane currently serves as Senior Director in Research and Development at Asklepios BioPharmaceutical, Inc. (AskBio), a position she has held since 2022. In this role, she contributes to the advancement of next-generation medicines through her extensive expertise in vector production and capsid development. Her focus on building effective teams enhances the collaborative environment necessary for innovative research and development.
Education and Expertise
Allison Dane earned a Bachelor of Medical Science with Honours (BMedSc Hons) from the University of Sydney, where she studied Medical Science from 1996 to 1999. She further pursued her academic career at the same institution, obtaining a Doctor of Philosophy (PhD) in Gene Therapy between 2008 and 2012. Her educational background supports her expertise in next-generation capsid development and vector production.
Background in Research and Development
Prior to her current role, Allison Dane held several positions in research and development. She worked as a Research Assistant at the Children's Medical Research Institute from 2002 to 2007 in Sydney, Australia. She later served as a Postdoctoral Researcher at University College London (UCL) from 2013 to 2015 and as a Senior Scientist at Freeline in London from 2015 to 2018. Following this, she advanced to the role of Scientific Director at Freeline, where she worked from 2018 until 2022.
Contributions to Next Generation Medicines
Allison Dane's work is centered on the development of next-generation medicines. She is driven by scientific curiosity and is dedicated to producing solid scientific work that contributes to advancements in the field. Her focus on team building and collaboration plays a crucial role in her contributions to innovative research initiatives.